Dr. Roy Beveridge joined Humana in 2013 as Senior Vice President and Chief Medical Officer. He is responsible for developing and implementing Humana’s clinical strategy, with an emphasis on advancing the company’s integrated care delivery model. Dr. Beveridge is known for creating collaborative environments among physician communities and providing thought leadership around population health. He is a member of Humana’s Management Team, which sets the strategic direction for the company.
Previously, Dr. Beveridge served as Chief Medical Officer for McKesson Specialty Health. Prior to McKesson’s acquisition of US Oncology in 2010, he served as the Executive Vice President and Medical Director at US Oncology. He has published extensively in the fields of medical oncology, stem cell transplantation, quality design and population health.
Dr. Beveridge earned a Bachelor of Arts degree from Johns Hopkins University and a medical degree from Cornell University Medical College. He completed his residency in internal medicine at University of Chicago Hospitals and his fellowship at Johns Hopkins Hospital. He is Board certified in medical oncology and internal medicine, Dr. Beveridge has authored more than two hundred articles on a wide range of medical topics such as hematology, stem cell transplantation and quality standardization, and population health/value-based medicine.
Dr. Beveridge is a member of the American Medical Association, American Society of Clinical Oncology (ASCO) and the American Society of Hematology. He has served on many boards related to medical oncology and patient advocacy.